To content
.
Investor Portal
Menu
Home
Team
Fund 3
News
Fund 3
Sustainability-related
disclosures
Contact
.
News
Vesalius News
04/28/2026
CatalYm: Christian S. Schade Chairman
read more
04/23/2026
CatalYm: Visugromab Phase 2/3
read more
04/07/2026
CatalYm: First Patient Visugromab
read more
.
xxnoxx_zaehler